drugset / Trial / NCT00414973

A Study for Patients With Osteoporosis

NCT00414973

Phase 3 Completed 364 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effect of injectable teriparatide to intranasal salmon calcitonin on lumbar spine bone mineral density, in the treatment of Chinese patients with established osteoporosis

Timeline

Start
2006-12
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Teriparatide Protein / enzyme biologic 20 ug Subcutaneous
Comparator salmon calcitonin Unknown 200 iu Intranasal

Indications